These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28600817)

  • 21. Dual Inhibition of PI3K/Akt and mTOR by the Dietary Antioxidant, Delphinidin, Ameliorates Psoriatic Features In Vitro and in an Imiquimod-Induced Psoriasis-Like Disease in Mice.
    Chamcheu JC; Adhami VM; Esnault S; Sechi M; Siddiqui IA; Satyshur KA; Syed DN; Dodwad SM; Chaves-Rodriquez MI; Longley BJ; Wood GS; Mukhtar H
    Antioxid Redox Signal; 2017 Jan; 26(2):49-69. PubMed ID: 27393705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A role for mitogen-activated protein kinase activation by integrins in the pathogenesis of psoriasis.
    Haase I; Hobbs RM; Romero MR; Broad S; Watt FM
    J Clin Invest; 2001 Aug; 108(4):527-36. PubMed ID: 11518726
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Paeonol ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice by inhibiting the maturation and activation of dendritic cells.
    Meng Y; Wang M; Xie X; Di T; Zhao J; Lin Y; Xu X; Li N; Zhai Y; Wang Y; Li P
    Int J Mol Med; 2017 May; 39(5):1101-1110. PubMed ID: 28339016
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Topical Sunitinib ointment alleviates Psoriasis-like inflammation by inhibiting the proliferation and apoptosis of keratinocytes.
    Kuang YH; Lu Y; Liu YK; Liao LQ; Zhou XC; Qin QS; Jia XK; Wu LS; Zhu W; Chen X
    Eur J Pharmacol; 2018 Apr; 824():57-63. PubMed ID: 29382533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Astilbin inhibits Th17 cell differentiation and ameliorates imiquimod-induced psoriasis-like skin lesions in BALB/c mice via Jak3/Stat3 signaling pathway.
    Di TT; Ruan ZT; Zhao JX; Wang Y; Liu X; Wang Y; Li P
    Int Immunopharmacol; 2016 Mar; 32():32-38. PubMed ID: 26784569
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human S100A7 Induces Mature Interleukin1α Expression by RAGE-p38 MAPK-Calpain1 Pathway in Psoriasis.
    Lei H; Li X; Jing B; Xu H; Wu Y
    PLoS One; 2017; 12(1):e0169788. PubMed ID: 28060905
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Baicalin Ameliorates Imiquimod-Induced Psoriasis-Like Inflammation in Mice.
    Hung CH; Wang CN; Cheng HH; Liao JW; Chen YT; Chao YW; Jiang JL; Lee CC
    Planta Med; 2018 Oct; 84(15):1110-1117. PubMed ID: 29763944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-17A upregulates keratin 17 expression in keratinocytes through STAT1- and STAT3-dependent mechanisms.
    Shi X; Jin L; Dang E; Chang T; Feng Z; Liu Y; Wang G
    J Invest Dermatol; 2011 Dec; 131(12):2401-8. PubMed ID: 21796151
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis.
    Ghoreschi K; Balato A; Enerbäck C; Sabat R
    Lancet; 2021 Feb; 397(10275):754-766. PubMed ID: 33515492
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Oncostatin M overexpression induces skin inflammation but is not required in the mouse model of imiquimod-induced psoriasis-like inflammation.
    Pohin M; Guesdon W; Mekouo AA; Rabeony H; Paris I; Atanassov H; Favot L; Mcheik J; Bernard FX; Richards CD; Amiaud J; Blanchard F; Lecron JC; Morel F; Jégou JF
    Eur J Immunol; 2016 Jul; 46(7):1737-51. PubMed ID: 27122058
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Imiquimod-induced psoriasis-like inflammation in differentiated Human keratinocytes: Its evaluation using curcumin.
    Varma SR; Sivaprakasam TO; Mishra A; Prabhu S; M R; P R
    Eur J Pharmacol; 2017 Oct; 813():33-41. PubMed ID: 28736282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dynamics of Asymmetric and Symmetric Divisions of Muscle Stem Cells In Vivo and on Artificial Niches.
    Evano B; Khalilian S; Le Carrou G; Almouzni G; Tajbakhsh S
    Cell Rep; 2020 Mar; 30(10):3195-3206.e7. PubMed ID: 32160529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. GPR43 activation enhances psoriasis-like inflammation through epidermal upregulation of IL-6 and dual oxidase 2 signaling in a murine model.
    Nadeem A; Ahmad SF; Al-Harbi NO; El-Sherbeeny AM; Al-Harbi MM; Almukhlafi TS
    Cell Signal; 2017 May; 33():59-68. PubMed ID: 28212864
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Egr-1 is a key regulator of IL-17A-induced psoriasin upregulation in psoriasis.
    Jeong SH; Kim HJ; Jang Y; Ryu WI; Lee H; Kim JH; Bae HC; Choi JE; Kye YC; Son SW
    Exp Dermatol; 2014 Dec; 23(12):890-5. PubMed ID: 25256120
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulation of TNIP1 Expression Leads to Increased Proliferation of Human Keratinocytes and Severer Psoriasis-Like Conditions in an Imiquimod-Induced Mouse Model of Dermatitis.
    Chen Y; Yan H; Song Z; Chen F; Wang H; Niu J; Shi X; Zhang D; Zhang N; Zhai Z; Zhong B; Cheng L; Qian T; Hao F
    PLoS One; 2015; 10(6):e0127957. PubMed ID: 26046540
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RIPK1 downregulation in keratinocyte enhances TRAIL signaling in psoriasis.
    Saito N; Honma M; Shibuya T; Iinuma S; Igawa S; Kishibe M; Ishida-Yamamoto A
    J Dermatol Sci; 2018 Jul; 91(1):79-86. PubMed ID: 29661487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PI3K/AKT/mTOR activation and autophagy inhibition plays a key role in increased cholesterol during IL-17A mediated inflammatory response in psoriasis.
    Varshney P; Saini N
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1795-1803. PubMed ID: 29432814
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IκBζ is a key transcriptional regulator of IL-36-driven psoriasis-related gene expression in keratinocytes.
    Müller A; Hennig A; Lorscheid S; Grondona P; Schulze-Osthoff K; Hailfinger S; Kramer D
    Proc Natl Acad Sci U S A; 2018 Oct; 115(40):10088-10093. PubMed ID: 30224457
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rottlerin as a therapeutic approach in psoriasis: Evidence from in vitro and in vivo studies.
    Min M; Yan BX; Wang P; Landeck L; Chen JQ; Li W; Cai SQ; Zheng M; Man XY
    PLoS One; 2017; 12(12):e0190051. PubMed ID: 29272319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Therapeutic Effects of Methanol Extract from
    Kim SJ; Jang YW; Hyung KE; Lee DK; Hyun KH; Park SY; Park ES; Hwang KW
    J Immunol Res; 2017; 2017():7052560. PubMed ID: 28761880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.